Apyx Medical
APYX
39 hedge funds and large institutions have $28.2M invested in Apyx Medical in 2017 Q3 according to their latest regulatory filings, with 11 funds opening new positions, 8 increasing their positions, 10 reducing their positions, and 10 closing their positions.
45% more capital invested
Capital invested by funds: $19.5M → $28.2M (+$8.68M)
10% more first-time investments, than exits
New positions opened: 11 | Existing positions closed: 10
0% more funds holding
Funds holding: 39 → 39 (0)
20% less repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 10
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $45K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RI
RTW Investments
New York
|
+$2.94M |
| 2 |
MAG
Millrace Asset Group
Berwyn,
Pennsylvania
|
+$813K |
| 3 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
+$232K |
| 4 |
ACM
Archon Capital Management
Seattle,
Washington
|
+$194K |
| 5 |
RJFSA
Raymond James Financial Services Advisors
St. Petersburg,
Florida
|
+$75.4K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GPP
Great Point Partners
Greenwich,
Connecticut
|
-$2.83M |
| 2 |
CPA
Cowen Prime Advisors
New York
|
-$195K |
| 3 |
Millennium Management
New York
|
-$61K |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$30K |
| 5 |
Squarepoint
New York
|
-$27K |
APYX Hedge Fund Activity: Q3 2017 in Review
39 of the 4,022 institutional investors tracked by Wall St. Rank reported a position in Apyx Medical (APYX) for Q3 2017, worth a combined $28.2M — up 45% from $19.5M a quarter earlier.
Buyers outnumbered sellers: 11 funds opened new APYX positions and 10 closed out — a net gain of 1 holder — while 8 added to existing stakes and 10 trimmed.
The largest buyer was RTW Investments, opening a new position worth an estimated $2.94M. The largest seller was Great Point Partners, cutting an estimated $2.83M.
- 39 institutional investors held Apyx Medical (APYX) as of Q3 2017, unchanged from Q2 2017.
- Funds reported $28.2M of Apyx Medical stock for Q3 2017, up 45% quarter-over-quarter.
- 11 funds opened new Apyx Medical positions in Q3 2017 and 10 closed out, a net change of +1 holder.
- The largest Apyx Medical buyer in Q3 2017 was RTW Investments, an estimated $2.94M added.
- The largest Apyx Medical seller in Q3 2017 was Great Point Partners, an estimated $2.83M sold.
Based on aggregated 13F filings for Q3 2017.